2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1669471959 MD
Verify on CMS →

MICHAEL MERCANDETTI, MD

Ophthalmic Plastic and Reconstructive Surgery Physician in VENICE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
689
Medicare Part D claims · 456 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
87.5203/100
▲ 4 pts above national avg 83.1 · [object Object]
Industry payments
$224.09
8 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAEL MERCANDETTI, MD is a Ophthalmic Plastic and Reconstructive Surgery Physician ([object Object]) practicing in VENICE, Florida with a Medicare Part D prescribing footprint of 689 claims across 456 beneficiaries — 8% brand-name prescribing . Their CMS MIPS Final Score of 87.5203/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $224.09 across 8 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAEL MERCANDETTI, MD reported a CMS MIPS final score of 87.5203 out of 100, above the 83.1 national average, and filed 689 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MICHAEL MERCANDETTI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MICHAEL MERCANDETTI, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 07/19/2005

NPI 1669471959

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

291 US NPIs in this specialty

Medicare Part D claims

689 10% vs specialty avg

2023 prescription claims

Specialty avg: 624

MIPS final score

87.5203/100 4.420300000000012% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Florida providers

Florida providers

Ophthalmic Plastic and Reconstructive Surgery Physician share within Florida

1. Ophthalmic Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmic Plastic and Reconstructive Surgery Physician share within Florida

Medicare quality performance — MIPS

MICHAEL MERCANDETTI, MD's 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average

High performer (top quartile)
MIPS Final Score
87.5203/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 87.5203/100 vs national avg 83.1

0%100%National avg83%87.5%
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 87.5203/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL MERCANDETTI, MD is a Ophthalmic Plastic and Reconstructive Surgery Physician provider practicing in VENICE, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1669471959. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL MERCANDETTI, MD appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 1499 E VENICE AVE UNIT B, VENICE, FL, 34292, with a listed phone of (941) 584-4039. NPI 1669471959 was issued on 07/19/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MERCANDETTI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 689 prescription claims written by this provider, covering 456 Medicare beneficiaries and totaling roughly $18K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 2.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.5203/100 for the 2023 performance year (Quality 100, Cost 58.401), compared with the national average of 83.1.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1499 E VENICE AVE UNIT B
VENICE, FL 34292

Provider Details

NPI 1669471959
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials MD
Gender Male
NPI Issued 07/19/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

87.5203
Final Score
Avg: 83.1
100
Quality
58.401
Cost
100
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL MERCANDETTI, MD. Source: openpaymentsdata.cms.gov.

Total received

$224

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to MICHAEL MERCANDETTI, MD. To verify MICHAEL MERCANDETTI, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MICHAEL MERCANDETTI, MD — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 689 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

689
Total Claims
$18K
Total Drug Cost
456
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
710
Total Day Supply
9,736
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$11K
Generic Drug Cost
$8K
Opioid Claims
14 (2.0% rate)
Antibiotic Claims
56

Patient Demographics

Average Patient Age
76.0 years
Avg HCC Risk Score
1.17
Gender Split
61% female / 39% male
Age Distribution
<65: 15, 65-74: 197, 75-84: 175, 85+: 69

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Erythromycin
Erythromycin Base
382
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
93
Cephalexin
27
Mupirocin
20
Ciprofloxacin Hcl
14
Doxycycline Hyclate
14
Ofloxacin
12
Triamcinolone Acetonide
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How MICHAEL MERCANDETTI, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

291
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

MICHAEL MERCANDETTI, MD's 689 claims are above the specialty average of 624.

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as MERCANDETTI.

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL MERCANDETTI, MD's specialty?
MICHAEL MERCANDETTI, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in VENICE, Florida. Credentials: MD.
How much does MICHAEL MERCANDETTI, MD prescribe under Medicare Part D?
In 2023, MICHAEL MERCANDETTI, MD wrote 689 Medicare Part D claims totaling $18K in drug costs for 456 beneficiaries.
What is MICHAEL MERCANDETTI, MD's Medicare quality score?
MICHAEL MERCANDETTI, MD has a CMS MIPS Final Score of 87.5203/100 (Quality: 100, Cost: 58.401). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL MERCANDETTI, MD located?
MICHAEL MERCANDETTI, MD is located at 1499 E VENICE AVE UNIT B, VENICE, FL, 34292. Phone: (941) 584-4039.
What is MICHAEL MERCANDETTI, MD's NPI number?
MICHAEL MERCANDETTI, MD's National Provider Identifier (NPI) is 1669471959, issued on 07/19/2005.
Does MICHAEL MERCANDETTI, MD prescribe more brand-name or generic drugs?
MICHAEL MERCANDETTI, MD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $11K in brand drug costs.
Does MICHAEL MERCANDETTI, MD prescribe opioids?
Yes, MICHAEL MERCANDETTI, MD had 14 opioid claims in 2023 with an opioid prescribing rate of 2.0%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 291 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does MICHAEL MERCANDETTI, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL MERCANDETTI, MD's most frequently prescribed drugs include Erythromycin, Neomycin-Polymyxin-Dexameth, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL MERCANDETTI, MD accept Medicare?
MICHAEL MERCANDETTI, MD appears in CMS Medicare data with 689 Part D claims and 456 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL MERCANDETTI, MD's credentials?
MICHAEL MERCANDETTI, MD's NPI is 1669471959 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology